25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Ironwood Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Ironwood Pharmaceuticals Inc together

I guess you are interested in Ironwood Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ironwood Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Ironwood Pharmaceuticals Inc

I send you an email if I find something interesting about Ironwood Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Ironwood Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Ironwood Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-2.01
Expected worth in 1 year
$-1.86
How sure are you?
55.0%

+ What do you gain per year?

Total Gains per Share
$0.16
Return On Investment
3.7%

For what price can you sell your share?

Current Price per Share
$4.19
Expected price per share
$3.855 - $5.205
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ironwood Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$4.19
Intrinsic Value Per Share
$-2.13 - $18.48
Total Value Per Share
$-4.14 - $16.47

2.2. Growth of Ironwood Pharmaceuticals Inc (5 min.)




Is Ironwood Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$321.7m$400.8m-$731.9m-221.1%

How much money is Ironwood Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money$2.3m-$229.3m$231.6m10,057.5%
Net Profit Margin1.5%-213.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Ironwood Pharmaceuticals Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ironwood Pharmaceuticals Inc?

Welcome investor! Ironwood Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Ironwood Pharmaceuticals Inc.

First you should know what it really means to hold a share of Ironwood Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Ironwood Pharmaceuticals Inc is $4.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ironwood Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ironwood Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-2.01. Based on the TTM, the Book Value Change Per Share is $0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ironwood Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-0.1%0.010.3%-1.47-35.0%-0.06-1.3%-0.14-3.5%
Usd Book Value Change Per Share0.061.3%0.040.9%-1.26-30.2%-0.03-0.8%-0.07-1.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.061.3%0.040.9%-1.26-30.2%-0.03-0.8%-0.07-1.7%
Usd Price Per Share6.52-9.08-10.98-10.79-12.59-
Price to Earnings Ratio-302.76--194.31-7.89--24.80--18.77-
Price-to-Total Gains Ratio118.47-50.56-27.30-38.74-26.91-
Price to Book Ratio-3.24--4.56-1.16-9.85-25.48-
Price-to-Total Gains Ratio118.47-50.56-27.30-38.74-26.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.19
Number of shares238
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.04-0.03
Usd Total Gains Per Share0.04-0.03
Gains per Quarter (238 shares)9.33-7.63
Gains per Year (238 shares)37.32-30.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1037270-31-41
2075640-61-72
301121010-92-103
401491380-122-134
501871750-153-165
602242120-183-196
702612490-214-227
802992860-244-258
903363230-275-289
1003733600-305-320

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%8.04.00.066.7%16.04.00.080.0%18.022.00.045.0%19.044.01.029.7%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%22.018.00.055.0%29.033.02.045.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.064.00.0%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%22.018.00.055.0%29.033.02.045.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Ironwood Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0550.039+40%-1.263+2396%-0.032+158%-0.073+232%
Book Value Per Share---2.014-1.998-1%2.086-197%0.757-366%0.381-629%
Current Ratio--3.9151.622+141%23.434-83%11.759-67%8.129-52%
Debt To Asset Ratio--1.8131.731+5%0.701+159%0.988+84%1.012+79%
Debt To Equity Ratio----0%0.520-100%5.072-100%9.633-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.0050.011-149%-1.467+27148%-0.055+924%-0.145+2593%
Free Cash Flow Per Share--0.2090.222-6%0.363-42%0.300-30%0.065+220%
Free Cash Flow To Equity Per Share---0.100-0.060-40%0.997-110%0.315-132%0.127-179%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--18.481--------
Intrinsic Value_10Y_min---2.128--------
Intrinsic Value_1Y_max--1.367--------
Intrinsic Value_1Y_min--0.182--------
Intrinsic Value_3Y_max--4.477--------
Intrinsic Value_3Y_min--0.208--------
Intrinsic Value_5Y_max--8.033--------
Intrinsic Value_5Y_min---0.138--------
Market Cap669306443.520-56%1041498332.1601514999918.340-31%1967258341.280-47%1824830181.682-43%2062150977.432-49%
Net Profit Margin---0.0090.015-160%-2.133+23316%-0.051+464%-0.419+4503%
Operating Margin--0.2860.305-6%-2.060+819%-0.059+121%-0.305+206%
Operating Ratio--0.7140.699+2%3.033-76%1.061-33%1.495-52%
Pb Ratio-2.080+36%-3.237-4.562+41%1.157-380%9.847-133%25.480-113%
Pe Ratio-194.566+36%-302.761-194.314-36%7.893-3936%-24.804-92%-18.773-94%
Price Per Share4.190-56%6.5209.075-28%10.978-41%10.789-40%12.592-48%
Price To Free Cash Flow Ratio5.009-56%7.79410.561-26%8.110-4%10.134-23%-24.384+413%
Price To Total Gains Ratio76.135-56%118.47350.561+134%27.299+334%38.744+206%26.912+340%
Quick Ratio--3.5961.500+140%23.143-84%11.481-69%8.722-59%
Return On Assets---0.0020.004-157%-0.407+18629%-0.030+1287%-0.054+2373%
Return On Equity----0%0.056-100%0.409-100%-0.1220%
Total Gains Per Share--0.0550.039+40%-1.263+2396%-0.032+158%-0.073+232%
Usd Book Value---321727000.000-331054750.000+3%400879000.000-180%142580000.000-326%71634525.000-549%
Usd Book Value Change Per Share--0.0550.039+40%-1.263+2396%-0.032+158%-0.073+232%
Usd Book Value Per Share---2.014-1.998-1%2.086-197%0.757-366%0.381-629%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.0050.011-149%-1.467+27148%-0.055+924%-0.145+2593%
Usd Free Cash Flow--33407000.00036589250.000-9%65839000.000-49%51016550.000-35%12009850.000+178%
Usd Free Cash Flow Per Share--0.2090.222-6%0.363-42%0.300-30%0.065+220%
Usd Free Cash Flow To Equity Per Share---0.100-0.060-40%0.997-110%0.315-132%0.127-179%
Usd Market Cap669306443.520-56%1041498332.1601514999918.340-31%1967258341.280-47%1824830181.682-43%2062150977.432-49%
Usd Price Per Share4.190-56%6.5209.075-28%10.978-41%10.789-40%12.592-48%
Usd Profit---860000.0002303000.000-137%-229322250.000+26565%-6453300.000+650%-21984600.000+2456%
Usd Revenue--94396000.000100141250.000-6%106819750.000-12%104167400.000-9%84442775.000+12%
Usd Total Gains Per Share--0.0550.039+40%-1.263+2396%-0.032+158%-0.073+232%
 EOD+2 -6MRQTTM+11 -20YOY+17 -165Y+17 -1610Y+20 -12

3.3 Fundamental Score

Let's check the fundamental score of Ironwood Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-194.566
Price to Book Ratio (EOD)Between0-1-2.080
Net Profit Margin (MRQ)Greater than0-0.009
Operating Margin (MRQ)Greater than00.286
Quick Ratio (MRQ)Greater than13.596
Current Ratio (MRQ)Greater than13.915
Debt to Asset Ratio (MRQ)Less than11.813
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.002
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Ironwood Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.967
Ma 20Greater thanMa 504.187
Ma 50Greater thanMa 1004.350
Ma 100Greater thanMa 2005.173
OpenGreater thanClose4.040
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, Saudi Arabia, and China, as well as under the CONSTELLA name in the Canada and European countries. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; Apraglutide, a next-generation, long-acting synthetic peptide analog of glucagon-like peptide-2, as a differentiated therapeutic for rare diseases, including short bowel syndrome dependent on parenteral support and acute graft versus host disease; and CNP-104, an immune nanoparticle for the treatment of primary biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2024-10-24 18:12:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Ironwood Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -0.9% means that $-0.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is -0.9%. The company is not making a profit/loss.
  • The TTM is 1.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM1.5%-2.4%
TTM1.5%YOY-213.3%+214.9%
TTM1.5%5Y-5.1%+6.7%
5Y-5.1%10Y-41.9%+36.8%
4.3.1.2. Return on Assets

Shows how efficient Ironwood Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.2% Return on Assets means that Ironwood Pharmaceuticals Inc generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is -0.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM0.4%-0.6%
TTM0.4%YOY-40.7%+41.1%
TTM0.4%5Y-3.0%+3.4%
5Y-3.0%10Y-5.4%+2.4%
4.3.1.3. Return on Equity

Shows how efficient Ironwood Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Ironwood Pharmaceuticals Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY5.6%-5.6%
TTM-5Y40.9%-40.9%
5Y40.9%10Y-12.2%+53.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Ironwood Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Ironwood Pharmaceuticals Inc is operating .

  • Measures how much profit Ironwood Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 28.6% means the company generated $0.29  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 28.6%. The company is operating very efficient. +2
  • The TTM is 30.5%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ28.6%TTM30.5%-1.9%
TTM30.5%YOY-206.0%+236.6%
TTM30.5%5Y-5.9%+36.5%
5Y-5.9%10Y-30.5%+24.5%
4.3.2.2. Operating Ratio

Measures how efficient Ironwood Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.71 means that the operating costs are $0.71 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 0.714. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.699. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.714TTM0.699+0.015
TTM0.699YOY3.033-2.334
TTM0.6995Y1.061-0.362
5Y1.06110Y1.495-0.435
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Ironwood Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ironwood Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.92 means the company has $3.92 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 3.915. The company is very able to pay all its short-term debts. +2
  • The TTM is 1.622. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.915TTM1.622+2.293
TTM1.622YOY23.434-21.812
TTM1.6225Y11.759-10.137
5Y11.75910Y8.129+3.630
4.4.3.2. Quick Ratio

Measures if Ironwood Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.60 means the company can pay off $3.60 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 3.596. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.500. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.596TTM1.500+2.095
TTM1.500YOY23.143-21.643
TTM1.5005Y11.481-9.981
5Y11.48110Y8.722+2.759
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Ironwood Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Ironwood Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ironwood Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.81 means that Ironwood Pharmaceuticals Inc assets are financed with 181.3% credit (debt) and the remaining percentage (100% - 181.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 1.813. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.731. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.813TTM1.731+0.082
TTM1.731YOY0.701+1.030
TTM1.7315Y0.988+0.743
5Y0.98810Y1.012-0.024
4.5.4.2. Debt to Equity Ratio

Measures if Ironwood Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.520-0.520
TTM-5Y5.072-5.072
5Y5.07210Y9.633-4.560
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ironwood Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -302.76 means the investor is paying $-302.76 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ironwood Pharmaceuticals Inc:

  • The EOD is -194.566. Based on the earnings, the company is expensive. -2
  • The MRQ is -302.761. Based on the earnings, the company is expensive. -2
  • The TTM is -194.314. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-194.566MRQ-302.761+108.195
MRQ-302.761TTM-194.314-108.447
TTM-194.314YOY7.893-202.207
TTM-194.3145Y-24.804-169.510
5Y-24.80410Y-18.773-6.031
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ironwood Pharmaceuticals Inc:

  • The EOD is 5.009. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.794. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 10.561. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD5.009MRQ7.794-2.785
MRQ7.794TTM10.561-2.767
TTM10.561YOY8.110+2.451
TTM10.5615Y10.134+0.428
5Y10.13410Y-24.384+34.518
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Ironwood Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Ironwood Pharmaceuticals Inc:

  • The EOD is -2.080. Based on the equity, the company is expensive. -2
  • The MRQ is -3.237. Based on the equity, the company is expensive. -2
  • The TTM is -4.562. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.080MRQ-3.237+1.157
MRQ-3.237TTM-4.562+1.325
TTM-4.562YOY1.157-5.719
TTM-4.5625Y9.847-14.409
5Y9.84710Y25.480-15.634
4.6.2. Total Gains per Share

2.4. Latest News of Ironwood Pharmaceuticals Inc

Does Ironwood Pharmaceuticals Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Ironwood Pharmaceuticals Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2024-10-16
14:58
Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts?Read

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ironwood Pharmaceuticals Inc.

4.8.1. Institutions holding Ironwood Pharmaceuticals Inc

Institutions are holding 110.098% of the shares of Ironwood Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc14.32150.003422877015-1280753-5.3016
2024-06-30Vanguard Group Inc13.49920.002721563414204204810.4606
2024-06-30Sarissa Capital Management LP10.260518.03831639000000
2024-06-30State Street Corp5.78620.00269242841-4674270-33.5865
2024-06-30Pacer Advisors, INC.5.57640.1316890763989076390
2024-06-30Renaissance Technologies Corp5.36620.09488571898147209720.7343
2024-06-30Armistice Capital, LLC4.8830.63997800000240000044.4444
2024-06-30LSV Asset Management3.80090.08676071501-79500-1.2925
2024-06-30Morgan Stanley - Brokerage Accounts3.0430.00254860828-495404-9.2491
2024-06-30BRAIDWELL LP2.77840.9078443823294838927.1757
2024-06-30Jacobs Levy Equity Management, Inc.2.72840.117543582981227182.8973
2024-06-30Geode Capital Management, LLC2.11110.001933723222251647.1545
2024-06-30Man Group PLC1.86830.04912984451-862-0.0289
2024-06-30Brown Capital Management, LLC1.61570.342580875-119830-4.437
2024-06-30JPMorgan Chase & Co1.160.001185300566778056.342
2024-06-30UBS Group AG1.15180.0031839799-1187916-39.2347
2024-06-30Amvescap Plc.1.04340.002316667661149803222.415
2024-06-30Kynam Capital Management, LP1.02790.82571641891168911.0394
2024-06-30Goldman Sachs Group Inc0.97870.0017156343218377013.3199
2024-06-30Charles Schwab Investment Management Inc0.96370.0019153943014702710.5592
Total 83.964321.2544134123637+10444791+7.8%

4.9.2. Funds holding Ironwood Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Pacer US Small Cap Cash Cows 100 ETF7.05470.504711269157-2848-0.0253
2024-09-30iShares Core S&P Small-Cap ETF5.62920.0438992022268940.3
2024-09-30SPDR® S&P Biotech ETF2.79550.2444465551-104157-2.2793
2024-08-31Vanguard Total Stock Mkt Idx Inv2.61980.00124184915574751.3925
2024-09-30iShares Russell 2000 ETF2.29360.0217366369400
2024-08-31Vanguard Small Cap Index2.1370.0115341363781740.24
2024-08-31Vanguard Institutional Extnd Mkt Idx Tr1.34850.0101215402033050.1537
2024-06-30Vanguard Strategic Equity Inv1.34240.168821442921099356105.208
2024-06-30Vanguard Explorer Inv1.30080.0623207796433115018.9574
2024-08-31Vanguard Small Cap Growth Index Inv1.18780.02681897424-8400-0.4408
2024-07-31Fidelity Small Cap Index0.92180.03531472534600454.251
2024-09-30SPDR® Portfolio S&P 600™ Sm Cap ETF0.80380.0447128405314160.1104
2024-09-30iShares Biotechnology ETF0.71290.0619113871121880.1925
2024-06-30Vanguard Strategic Small-Cap Equity Inv0.6960.4615111180554764197.0712
2024-08-31Vanguard Tax-Managed Small Cap Adm0.65990.056105419000
2024-06-30First Eagle US Small Cap Strategy0.62950.3491005503865189.4145
2024-09-30Xtrackers S&P 500 Swap ETF 1C0.61180.038597733900
2024-09-30iShares Russell 2000 Value ETF0.54730.028887428000
2024-09-30State St Russell Sm/Mid Cp® Indx NL Cl C0.53740.007685851600
2024-08-31Fidelity Extended Market Index0.52020.01830957-13372-1.5837
Total 34.34992.187454870564+2095385+3.8%

5.3. Insider Transactions

Insiders are holding 1.689% of the shares of Ironwood Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-08-12Minardo JohnSELL99104.27
2024-06-10Julie MchughSELL227666.29
2024-06-06Catherine MoukheibirSELL444266.36
2024-03-06Jon R DuaneBUY69208.7
2024-03-04Sravan Kumar EmanyBUY106849.38
2024-02-12Andrew DavisSELL984615.24
2024-02-12Michael ShetzlineSELL3861815.24
2024-02-12Minardo JohnSELL4738015.24
2024-02-12Thomas A MccourtSELL17716415.24
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets395,620
Total Liabilities717,347
Total Stockholder Equity-321,727
 As reported
Total Liabilities 717,347
Total Stockholder Equity+ -321,727
Total Assets = 395,620

Assets

Total Assets395,620
Total Current Assets178,180
Long-term Assets217,440
Total Current Assets
Cash And Cash Equivalents 105,524
Net Receivables 58,108
Other Current Assets 14,548
Total Current Assets  (as reported)178,180
Total Current Assets  (calculated)178,180
+/-0
Long-term Assets
Property Plant Equipment 16,891
Intangible Assets 3,273
Long-term Assets Other 4,257
Long-term Assets  (as reported)217,440
Long-term Assets  (calculated)24,421
+/- 193,019

Liabilities & Shareholders' Equity

Total Current Liabilities45,510
Long-term Liabilities671,837
Total Stockholder Equity-321,727
Total Current Liabilities
Short-term Debt 3,157
Accounts payable 3,227
Other Current Liabilities 38,191
Total Current Liabilities  (as reported)45,510
Total Current Liabilities  (calculated)44,575
+/- 935
Long-term Liabilities
Long term Debt 623,647
Capital Lease Obligations Min Short Term Debt13,452
Long-term Liabilities Other 34,738
Long-term Liabilities  (as reported)671,837
Long-term Liabilities  (calculated)671,837
+/-0
Total Stockholder Equity
Common Stock160
Retained Earnings -1,703,637
Accumulated Other Comprehensive Income -470
Other Stockholders Equity 1,382,220
Total Stockholder Equity (as reported)-321,727
Total Stockholder Equity (calculated)-321,727
+/-0
Other
Capital Stock160
Cash and Short Term Investments 105,524
Common Stock Shares Outstanding 159,014
Current Deferred Revenue935
Liabilities and Stockholders Equity 395,620
Net Debt 534,732
Net Invested Capital 301,920
Net Working Capital 132,670
Property Plant and Equipment Gross 16,891
Short Long Term Debt Total 640,256



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312007-12-31
> Total Assets 
135,908
140,723
0
0
158,847
162,451
338,130
322,084
304,500
301,365
272,024
249,727
219,480
208,977
249,176
208,663
246,518
229,907
325,093
384,031
325,843
278,962
418,871
371,064
346,168
333,513
305,528
653,941
613,426
619,121
603,325
700,208
731,978
709,821
701,319
705,079
625,086
605,674
571,095
618,218
416,652
332,050
363,538
315,721
334,343
402,748
404,005
443,538
492,324
559,238
599,344
1,007,218
1,079,371
1,126,927
1,083,381
975,690
1,040,344
1,100,519
1,155,277
603,220
524,063
471,073
438,819
395,620
395,620438,819471,073524,063603,2201,155,2771,100,5191,040,344975,6901,083,3811,126,9271,079,3711,007,218599,344559,238492,324443,538404,005402,748334,343315,721363,538332,050416,652618,218571,095605,674625,086705,079701,319709,821731,978700,208603,325619,121613,426653,941305,528333,513346,168371,064418,871278,962325,843384,031325,093229,907246,518208,663249,176208,977219,480249,727272,024301,365304,500322,084338,130162,451158,84700140,723135,908
   > Total Current Assets 
0
108,086
0
0
126,996
131,448
306,398
282,159
263,300
259,075
229,052
208,382
178,766
167,567
206,265
166,083
202,347
184,440
275,634
335,780
275,826
229,128
371,305
325,760
304,081
289,730
263,876
526,959
505,779
500,205
495,701
386,142
382,804
380,181
357,853
341,487
314,053
311,596
275,727
279,542
248,548
266,435
201,832
220,985
257,638
306,852
333,943
374,275
433,317
495,839
538,246
620,268
695,374
745,225
710,101
617,826
698,994
780,626
866,374
317,599
253,610
233,288
208,174
178,180
178,180208,174233,288253,610317,599866,374780,626698,994617,826710,101745,225695,374620,268538,246495,839433,317374,275333,943306,852257,638220,985201,832266,435248,548279,542275,727311,596314,053341,487357,853380,181382,804386,142495,701500,205505,779526,959263,876289,730304,081325,760371,305229,128275,826335,780275,634184,440202,347166,083206,265167,567178,766208,382229,052259,075263,300282,159306,398131,448126,99600108,0860
       Cash And Cash Equivalents 
62,427
67,722
0
0
96,269
123,145
76,338
35,384
58,700
44,321
46,214
48,185
68,820
87,282
131,612
87,083
125,867
136,700
105,302
219,461
144,452
75,490
205,129
95,357
51,269
74,297
63,692
256,450
248,077
261,287
280,926
277,332
182,937
54,004
133,319
182,132
162,640
125,736
144,788
145,415
141,562
173,172
119,045
98,908
139,231
177,023
231,143
253,252
307,555
362,564
438,469
492,699
574,276
620,129
593,371
504,365
574,188
656,203
740,342
175,321
110,164
92,154
121,540
105,524
105,524121,54092,154110,164175,321740,342656,203574,188504,365593,371620,129574,276492,699438,469362,564307,555253,252231,143177,023139,23198,908119,045173,172141,562145,415144,788125,736162,640182,132133,31954,004182,937277,332280,926261,287248,077256,45063,69274,29751,26995,357205,12975,490144,452219,461105,302136,700125,86787,083131,61287,28268,82048,18546,21444,32158,70035,38476,338123,14596,2690067,72262,427
       Short-term Investments 
29,509
22,045
0
0
17,659
0
222,230
236,221
192,100
203,706
174,355
152,912
106,309
76,734
70,496
70,570
67,456
31,528
136,727
81,077
97,938
122,112
127,140
206,621
213,692
174,037
152,173
236,865
214,229
178,107
153,526
48,041
136,936
251,212
162,020
90,763
62,777
95,680
49,659
35,831
19,836
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000019,83635,83149,65995,68062,77790,763162,020251,212136,93648,041153,526178,107214,229236,865152,173174,037213,692206,621127,140122,11297,93881,077136,72731,52867,45670,57070,49676,734106,309152,912174,355203,706192,100236,221222,230017,6590022,04529,509
       Net Receivables 
0
7,121
0
0
9,919
5,234
4,723
6,352
5,000
2,895
4,184
2,627
741
652
109
2,466
182
1,487
48
5,298
3,086
3,213
10,337
4,455
14,686
25,839
33,849
27,049
36,971
54,518
53,018
53,147
53,715
64,854
51,147
60,357
80,083
82,157
70,651
80,519
65,375
80,950
72,617
103,786
96,570
117,246
91,107
105,379
113,250
122,351
87,152
102,252
101,773
114,042
105,515
102,357
116,545
115,458
115,749
118,990
124,546
129,122
72,015
58,108
58,10872,015129,122124,546118,990115,749115,458116,545102,357105,515114,042101,773102,25287,152122,351113,250105,37991,107117,24696,570103,78672,61780,95065,37580,51970,65182,15780,08360,35751,14764,85453,71553,14753,01854,51836,97127,04933,84925,83914,6864,45510,3373,2133,0865,298481,4871822,4661096527412,6274,1842,8955,0006,3524,7235,2349,919007,1210
       Inventory 
0
2,498
0
0
0
0
-295,461
0
0
0
-216,270
0
0
0
-198,060
-151,689
965
6,699
19,704
20,379
20,561
22,145
23,413
12,989
13,045
4,954
4,950
0
0
0
0
0
0
1,081
1,513
0
479
735
1,705
1,099
76
0
593
1,735
2,298
648
0
0
0
0
0
0
0
0
0
0
0
1,250
1,250
788
788
0
0
0
0007887881,2501,250000000000006482,2981,7355930761,0991,70573547901,5131,0810000004,9504,95413,04512,98923,41322,14520,56120,37919,7046,699965-151,689-198,060000-216,270000-295,46100002,4980
   > Long-term Assets 
0
32,637
0
0
31,851
31,003
31,732
39,925
41,200
42,290
42,972
41,345
40,714
41,410
42,911
42,580
44,171
45,467
49,459
48,251
50,017
49,834
47,566
45,304
42,087
43,783
41,652
126,982
107,647
118,916
107,624
314,066
349,174
329,640
343,466
363,592
311,033
294,078
295,368
338,676
168,104
65,615
161,706
94,736
76,705
95,896
70,062
69,263
59,007
63,399
61,098
386,950
383,997
381,702
373,280
357,864
341,350
319,893
288,903
285,621
270,453
237,785
230,645
217,440
217,440230,645237,785270,453285,621288,903319,893341,350357,864373,280381,702383,997386,95061,09863,39959,00769,26370,06295,89676,70594,736161,70665,615168,104338,676295,368294,078311,033363,592343,466329,640349,174314,066107,624118,916107,647126,98241,65243,78342,08745,30447,56649,83450,01748,25149,45945,46744,17142,58042,91141,41040,71441,34542,97242,29041,20039,92531,73231,00331,8510032,6370
       Property Plant Equipment 
4,146
24,596
0
0
23,403
22,551
23,540
29,117
33,300
34,369
35,074
33,484
32,875
33,625
35,140
34,859
36,470
37,537
36,100
35,013
37,231
37,376
35,524
33,560
30,415
29,826
27,477
25,017
23,183
21,075
19,446
17,939
18,842
20,512
18,633
17,854
17,175
17,274
16,844
16,335
16,161
17,270
103,850
32,234
31,174
30,172
29,611
28,346
26,192
25,505
24,780
24,080
23,578
22,925
22,257
21,664
21,025
20,311
19,689
19,195
18,586
18,171
17,496
16,891
16,89117,49618,17118,58619,19519,68920,31121,02521,66422,25722,92523,57824,08024,78025,50526,19228,34629,61130,17231,17432,234103,85017,27016,16116,33516,84417,27417,17517,85418,63320,51218,84217,93919,44621,07523,18325,01727,47729,82630,41533,56035,52437,37637,23135,01336,10037,53736,47034,85935,14033,62532,87533,48435,07434,36933,30029,11723,54022,55123,4030024,5964,146
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
649
649
785
785
785
785
785
785
785
785
785
785
785
785
785
0
0
0
785
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000007850007857857857857857857857857857857857857856496490000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,314
72,494
86,466
77,688
99,478
137,302
132,521
150,509
171,880
121,836
108,188
113,445
159,526
142,774
41,020
50,589
60,720
43,755
63,963
38,642
39,126
31,449
36,466
34,909
23,706
23,852
23,998
14,143
14,289
14,439
14,589
0
0
0
0
0
0
00000014,58914,43914,28914,14323,99823,85223,70634,90936,46631,44939,12638,64263,96343,75560,72050,58941,020142,774159,526113,445108,188121,836171,880150,509132,521137,30299,47877,68886,46672,49490,314000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
186,584
183,371
166,119
165,699
165,278
163,381
159,905
156,429
152,953
785
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,096
3,889
3,682
3,478
3,273
3,2733,4783,6823,8894,096000000000000000000785152,953156,429159,905163,381165,278165,699166,119183,371186,5840000000000000000000000000000000
       Long-term Assets Other 
0
8,041
0
0
8,448
8,452
8,192
10,808
7,900
7,921
7,898
7,861
7,839
7,785
7,771
7,721
7,701
7,930
13,359
13,238
12,786
12,458
12,042
11,744
11,672
13,957
14,175
101,965
84,464
97,841
88,178
109,543
146,961
142,224
158,349
179,675
129,692
116,114
121,310
168,603
151,158
47,560
57,071
61,717
44,746
64,939
40,451
40,917
32,815
37,109
36,318
25,070
25,192
25,483
15,583
15,646
15,787
15,921
1,305
3,920
3,823
3,608
3,398
4,257
4,2573,3983,6083,8233,9201,30515,92115,78715,64615,58325,48325,19225,07036,31837,10932,81540,91740,45164,93944,74661,71757,07147,560151,158168,603121,310116,114129,692179,675158,349142,224146,961109,54388,17897,84184,464101,96514,17513,95711,67211,74412,04212,45812,78613,23813,3597,9307,7017,7217,7717,7857,8397,8617,8987,9217,90010,8088,1928,4528,448008,0410
> Total Liabilities 
90,480
371,134
0
0
135,640
460,791
149,328
148,534
136,500
141,814
127,439
119,610
106,550
99,121
85,030
79,882
64,410
85,855
266,570
244,615
241,634
240,737
229,928
229,233
238,018
244,961
237,366
513,658
512,968
523,996
512,390
618,827
672,520
643,105
671,682
700,209
642,665
595,826
589,147
662,169
613,947
528,421
600,717
535,088
487,390
495,999
475,562
480,390
486,420
496,598
489,152
495,462
499,430
521,016
565,598
442,807
449,281
448,141
448,425
949,997
849,742
817,368
769,337
717,347
717,347769,337817,368849,742949,997448,425448,141449,281442,807565,598521,016499,430495,462489,152496,598486,420480,390475,562495,999487,390535,088600,717528,421613,947662,169589,147595,826642,665700,209671,682643,105672,520618,827512,390523,996512,968513,658237,366244,961238,018229,233229,928240,737241,634244,615266,57085,85564,41079,88285,03099,121106,550119,610127,439141,814136,500148,534149,328460,791135,64000371,13490,480
   > Total Current Liabilities 
29,931
39,152
0
0
51,139
56,437
54,984
57,201
55,800
64,426
60,532
70,844
70,848
65,134
52,283
49,121
35,577
54,938
62,682
43,966
39,701
41,040
38,500
41,626
54,057
60,541
59,813
62,099
67,780
76,465
78,113
90,999
95,305
91,131
78,893
79,973
64,489
66,027
62,336
94,984
112,582
119,524
118,569
110,861
52,795
40,929
27,595
26,695
32,901
32,713
23,603
134,370
145,694
161,698
147,403
23,298
27,117
25,525
23,843
305,390
280,579
276,101
252,442
45,510
45,510252,442276,101280,579305,39023,84325,52527,11723,298147,403161,698145,694134,37023,60332,71332,90126,69527,59540,92952,795110,861118,569119,524112,58294,98462,33666,02764,48979,97378,89391,13195,30590,99978,11376,46567,78062,09959,81360,54154,05741,62638,50041,04039,70143,96662,68254,93835,57749,12152,28365,13470,84870,84460,53264,42655,80057,20154,98456,43751,1390039,15229,931
       Short-term Debt 
0
1,060
0
0
1,554
1,453
1,509
1,263
227
197
241
229
228
233
271
277
280
261
242
223
1,115
1,139
5,537
7,681
10,475
12,410
14,384
18,774
22,446
27,595
30,689
37,710
11,930
6,227
5,501
5,097
4,411
4,077
15,317
27,326
39,362
47,627
58,041
60,701
9,934
1,146
1,876
2,610
3,112
3,128
3,144
116,013
117,989
119,985
123,678
3,066
3,050
3,065
3,080
202,178
202,432
202,686
202,942
3,157
3,157202,942202,686202,432202,1783,0803,0653,0503,066123,678119,985117,989116,0133,1443,1283,1122,6101,8761,1469,93460,70158,04147,62739,36227,32615,3174,0774,4115,0975,5016,22711,93037,71030,68927,59522,44618,77414,38412,41010,4757,6815,5371,1391,1152232422612802772712332282292411972271,2631,5091,4531,554001,0600
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,258
0
0
0
24,964
30,689
37,710
11,930
372,801
5,501
392,957
396,340
400,168
11,958
24,861
39,191
47,554
45,961
48,797
0
0
0
0
0
0
0
112,852
114,832
116,858
120,581
0
0
0
0
199,083
199,321
199,560
199,800
0
0199,800199,560199,321199,0830000120,581116,858114,832112,852000000048,79745,96147,55439,19124,86111,958400,168396,340392,9575,501372,80111,93037,71030,68924,96400011,2580000000000000000000000000
       Accounts payable 
5,585
6,086
0
0
6,434
4,944
17,868
5,202
5,900
4,302
17,364
6,507
2,390
6,436
3,171
10,626
4,793
48,561
29,744
35,907
30,736
32,037
24,032
24,681
35,042
35,948
33,232
31,125
33,117
36,135
4,741
36,250
56,849
62,941
20,578
21,190
17,514
61,508
46,427
66,993
9,332
71,594
11,203
9,908
6,098
5,487
3,839
2,855
2,372
661
842
466
414
935
532
317
795
483
118
3,505
4,698
7,830
6,222
3,227
3,2276,2227,8304,6983,5051184837953175329354144668426612,3722,8553,8395,4876,0989,90811,20371,5949,33266,99346,42761,50817,51421,19020,57862,94156,84936,2504,74136,13533,11731,12533,23235,94835,04224,68124,03232,03730,73635,90729,74448,5614,79310,6263,1716,4362,3906,50717,3644,3025,9005,20217,8684,9446,434006,0865,585
       Other Current Liabilities 
23,340
13,994
0
0
10,241
17,300
12,752
14,096
14,183
19,877
14,446
15,553
20,583
22,174
23,906
24,640
27,374
2,735
29,397
2,762
2,776
2,790
2,803
2,817
3,466
4,992
5,006
5,009
5,026
5,544
33,374
8,520
22,399
14,772
52,073
53,461
699
247
355
423
50,367
51
16,817
15,025
35,485
33,421
21,005
20,355
26,542
540
1,878
2,157
5,489
1,316
23,193
19,915
23,272
21,977
20,645
99,707
14,301
64,341
41,378
38,191
38,19141,37864,34114,30199,70720,64521,97723,27219,91523,1931,3165,4892,1571,87854026,54220,35521,00533,42135,48515,02516,8175150,36742335524769953,46152,07314,77222,3998,52033,3745,5445,0265,0095,0064,9923,4662,8172,8032,7902,7762,76229,3972,73527,37424,64023,90622,17420,58315,55314,44619,87714,18314,09612,75217,30010,2410013,99423,340
   > Long-term Liabilities 
0
331,982
0
0
84,501
404,354
94,344
91,333
80,700
77,388
66,907
48,766
35,702
33,987
32,747
30,761
28,833
30,917
203,888
200,649
201,933
199,697
191,428
187,607
183,961
184,420
177,553
451,559
445,188
447,531
434,277
527,828
577,215
551,974
592,789
620,236
578,176
529,799
526,811
567,185
501,365
408,897
482,148
424,227
434,595
455,070
447,967
453,695
453,519
463,885
465,549
361,092
353,736
359,318
418,195
419,509
422,164
422,616
424,582
644,607
569,163
541,267
516,895
671,837
671,837516,895541,267569,163644,607424,582422,616422,164419,509418,195359,318353,736361,092465,549463,885453,519453,695447,967455,070434,595424,227482,148408,897501,365567,185526,811529,799578,176620,236592,789551,974577,215527,828434,277447,531445,188451,559177,553184,420183,961187,607191,428199,697201,933200,649203,88830,91728,83330,76132,74733,98735,70248,76666,90777,38880,70091,33394,344404,35484,50100331,9820
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
540
481
422
435
364
361
308
174,855
174,826
178,077
177,806
173,154
171,297
168,260
164,909
160,427
364,044
360,257
353,890
348,833
339,409
362,802
366,574
383,909
387,860
391,929
396,091
388,373
379,820
369,944
366,296
360,087
352,725
402,675
407,994
413,409
418,924
424,539
430,256
436,078
329,155
333,212
337,333
395,053
395,451
395,850
396,251
396,653
597,974
0
0
0
0
0000597,974396,653396,251395,850395,451395,053337,333333,212329,155436,078430,256424,539418,924413,409407,994402,675352,725360,087366,296369,944379,820388,373396,091391,929387,860383,909366,574362,802339,409348,833353,890360,257364,044160,427164,909168,260171,297173,154177,806178,077174,826174,85530836136443542248154000000000000
       Capital Lease Obligations Min Short Term Debt
0
-1,060
0
0
-1,554
-1,453
-1,509
-1,263
-227
-197
-241
311
253
189
164
87
81
47
12
-25
2,312
1,995
-2,695
-4,523
-7,607
-9,839
-12,116
-16,815
-21,378
-27,289
-30,436
-37,512
-11,789
-6,145
-5,480
-5,097
-4,411
-4,077
-15,317
-27,326
-39,362
-47,469
33,989
-30,112
22,660
22,082
21,646
21,211
20,767
20,318
19,862
-93,458
-95,902
-98,374
-102,550
17,567
17,087
16,599
16,105
-183,485
-184,247
-185,017
-185,796
13,452
13,452-185,796-185,017-184,247-183,48516,10516,59917,08717,567-102,550-98,374-95,902-93,45819,86220,31820,76721,21121,64622,08222,660-30,11233,989-47,469-39,362-27,326-15,317-4,077-4,411-5,097-5,480-6,145-11,789-37,512-30,436-27,289-21,378-16,815-12,116-9,839-7,607-4,523-2,6951,9952,312-2512478187164189253311-241-197-227-1,263-1,509-1,453-1,55400-1,0600
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
703
0
0
0
0
0
992
909
1,653
1,653
1,653
0
0
0
0
0
3,845
10,645
10,120
10,120
97,172
91,802
71,606
72,902
79,403
78,020
36,071
36,449
38,288
2,530
2,530
2,723
2,626
492
734
705
602
518
1,763
1,630
1,482
1,594
3,501
5,111
6,491
9,227
9,766
11,824
31,035
30,948
28,415
29,414
34,738
34,73829,41428,41530,94831,03511,8249,7669,2276,4915,1113,5011,5941,4821,6301,7635186027057344922,6262,7232,5302,53038,28836,44936,07178,02079,40372,90271,60691,80297,17210,12010,12010,6453,845000001,6531,6531,6539099920000070300000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
47,523
35,221
33,565
32,312
30,397
28,472
29,617
28,124
24,170
22,203
20,238
18,274
16,310
15,701
19,511
17,126
83,670
74,286
83,521
75,324
91,247
122,611
113,794
135,978
152,973
108,227
97,637
101,989
149,077
128,891
40,071
39,388
50,191
8,768
24,260
12,207
12,958
7,695
12,088
7,979
11,061
0
0
0
0
0
0
0
2,800
0
0
0
0
00002,800000000011,0617,97912,0887,69512,95812,20724,2608,76850,19139,38840,071128,891149,077101,98997,637108,227152,973135,978113,794122,61191,24775,32483,52174,28683,67017,12619,51115,70116,31018,27420,23822,20324,17028,12429,61728,47230,39732,31233,56535,22147,52300000000000
> Total Stockholder Equity
38,933
-235,750
0
0
19,351
-301,552
188,802
170,740
168,100
159,551
144,585
130,117
112,930
109,856
164,146
128,781
182,108
144,052
58,523
139,416
84,209
38,225
188,943
141,831
108,150
88,552
68,162
140,283
100,458
95,125
90,935
81,381
59,458
66,716
29,637
4,870
-17,579
9,848
-18,052
-43,951
-197,295
-196,371
-237,179
-219,367
-153,047
-93,251
-71,557
-36,852
5,904
62,640
110,192
511,756
579,941
605,911
517,783
532,883
591,063
652,378
706,852
-346,777
-325,679
-346,295
-330,518
-321,727
-321,727-330,518-346,295-325,679-346,777706,852652,378591,063532,883517,783605,911579,941511,756110,19262,6405,904-36,852-71,557-93,251-153,047-219,367-237,179-196,371-197,295-43,951-18,0529,848-17,5794,87029,63766,71659,45881,38190,93595,125100,458140,28368,16288,552108,150141,831188,94338,22584,209139,41658,523144,052182,108128,781164,146109,856112,930130,117144,585159,551168,100170,740188,802-301,55219,35100-235,75038,933
   Common Stock
7
7
0
0
78
8
98
98
100
99
100
100
101
101
107
108
108
108
109
121
121
121
138
138
140
141
142
142
143
143
144
145
146
148
149
150
149
151
152
153
154
154
156
156
157
158
159
160
160
161
162
163
163
162
155
153
153
154
155
156
156
156
159
160
1601591561561561551541531531551621631631621611601601591581571561561541541531521511491501491481461451441431431421421411401381381211211211091081081081071011011001009910098988780077
   Retained Earnings Total Equity0000-1,712,849-650,662-696,376-745,243-795,560-832,640-937,608-978,982-1,034,827-1,426,130-1,466,056-1,509,260-1,543,683-1,568,887-1,572,232-1,620,090-1,640,738-1,650,412-1,591,128-1,575,635-1,401,284-1,351,904-1,308,760-1,320,845-1,288,548-1,244,324-1,191,823-1,178,318-1,145,114-1,123,412-1,110,115-1,096,078-1,048,688-1,000,668-967,446-929,799-887,811-827,454-777,828-725,842-664,067-598,918-505,016-461,161-508,796-467,993-432,392-425,418-404,78500000000000
   Accumulated Other Comprehensive Income 
0
23
0
0
2
-298,350
-99
44
48
1
52
53
6
6
3
-9
7
5
12
-1
19
2
-12
3
25
-19
3
22
48
-86
29
39
61
-7
-41
-24
-6
-79
-91
-44
-9
-65,228
0
0
0
-10,082
0
0
0
-11,805
0
0
0
0
0
0
0
0
0
0
-752
-3,031
-922
-470
-470-922-3,031-7520000000000-11,805000-10,082000-65,228-9-44-91-79-6-24-41-7613929-8648223-19253-12219-11257-9366535214844-99-298,350200230
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
534,749
538,241
542,141
632,029
637,478
643,154
648,955
657,320
803,363
809,911
815,930
1,016,271
1,029,501
1,037,784
1,055,876
1,068,685
1,188,807
1,196,345
1,205,183
1,214,174
1,226,311
1,237,569
1,258,398
1,273,853
1,293,292
1,303,123
1,318,536
1,333,791
1,357,224
1,378,195
1,394,603
1,413,077
1,421,215
1,466,886
1,478,823
1,497,171
1,506,671
1,515,004
1,528,535
1,536,160
1,546,420
1,558,760
1,543,357
1,350,268
1,328,290
1,336,153
1,348,600
1,357,359
1,366,989
0
0
0
0
00001,366,9891,357,3591,348,6001,336,1531,328,2901,350,2681,543,3571,558,7601,546,4201,536,1601,528,5351,515,0041,506,6711,497,1711,478,8231,466,8861,421,2151,413,0771,394,6031,378,1951,357,2241,333,7911,318,5361,303,1231,293,2921,273,8531,258,3981,237,5691,226,3111,214,1741,205,1831,196,3451,188,8071,068,6851,055,8761,037,7841,029,5011,016,271815,930809,911803,363657,320648,955643,154637,478632,029542,141538,241534,74900000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
7,594
0
0
309,307
12,999
516,403
518,217
523,852
526,991
530,374
534,749
538,241
542,141
632,029
637,478
643,154
648,955
657,320
803,363
809,911
815,930
1,016,271
1,029,501
1,037,784
1,055,876
1,068,685
1,188,807
1,196,345
1,205,183
1,214,174
1,226,311
1,237,569
1,258,398
1,273,853
1,293,292
1,303,123
1,318,536
1,333,791
1,357,224
1,378,195
1,394,603
1,413,077
1,421,215
1,466,886
1,488,905
1,497,171
1,506,671
1,515,004
1,540,340
1,536,160
1,546,420
1,558,760
1,543,357
1,350,268
1,328,290
1,336,153
1,348,600
1,357,359
1,365,916
1,372,445
1,355,195
1,373,022
1,382,220
1,382,2201,373,0221,355,1951,372,4451,365,9161,357,3591,348,6001,336,1531,328,2901,350,2681,543,3571,558,7601,546,4201,536,1601,540,3401,515,0041,506,6711,497,1711,488,9051,466,8861,421,2151,413,0771,394,6031,378,1951,357,2241,333,7911,318,5361,303,1231,293,2921,273,8531,258,3981,237,5691,226,3111,214,1741,205,1831,196,3451,188,8071,068,6851,055,8761,037,7841,029,5011,016,271815,930809,911803,363657,320648,955643,154637,478632,029542,141538,241534,749530,374526,991523,852518,217516,40312,999309,307007,5940



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue442,735
Cost of Revenue-1,575
Gross Profit441,160441,160
 
Operating Income (+$)
Gross Profit441,160
Operating Expense-232,124
Operating Income209,036209,036
 
Operating Expense (+$)
Research Development99,410
Selling General Administrative148,037
Selling And Marketing Expenses0
Operating Expense232,124247,447
 
Net Interest Income (+$)
Interest Income23,223
Interest Expense-21,629
Other Finance Cost-6,897
Net Interest Income8,491
 
Pretax Income (+$)
Operating Income209,036
Net Interest Income8,491
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-948,0691,366,141
EBIT - interestExpense = 187,407
-918,749
-980,610
Interest Expense21,629
Earnings Before Interest and Taxes (EBIT)209,036-926,440
Earnings Before Interest and Taxes (EBITDA)210,611
 
After tax Income (+$)
Income Before Tax-948,069
Tax Provision-74,783
Net Income From Continuing Ops-980,947-1,022,852
Net Income-1,002,239
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses233,699
Total Other Income/Expenses Net-1,157,105-8,491
 

Technical Analysis of Ironwood Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ironwood Pharmaceuticals Inc. The general trend of Ironwood Pharmaceuticals Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ironwood Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ironwood Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.57 < 4.795 < 5.205.

The bearish price targets are: 3.895 > 3.8633 > 3.855.

Tweet this
Ironwood Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ironwood Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ironwood Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ironwood Pharmaceuticals Inc. The current macd is -0.07517811.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ironwood Pharmaceuticals Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ironwood Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ironwood Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Ironwood Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartIronwood Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ironwood Pharmaceuticals Inc. The current adx is 17.90.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ironwood Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Ironwood Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ironwood Pharmaceuticals Inc. The current sar is 4.46897505.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ironwood Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ironwood Pharmaceuticals Inc. The current rsi is 48.97. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Ironwood Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartIronwood Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ironwood Pharmaceuticals Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ironwood Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Ironwood Pharmaceuticals Inc Daily Stochastic Oscillator ChartIronwood Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ironwood Pharmaceuticals Inc. The current cci is -37.66093812.

Ironwood Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartIronwood Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ironwood Pharmaceuticals Inc. The current cmo is 2.9648354.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Ironwood Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartIronwood Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ironwood Pharmaceuticals Inc. The current willr is -56.2962963.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ironwood Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ironwood Pharmaceuticals Inc Daily Williams %R ChartIronwood Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ironwood Pharmaceuticals Inc. The current atr is 0.24491442.

Ironwood Pharmaceuticals Inc Daily Average True Range (ATR) ChartIronwood Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ironwood Pharmaceuticals Inc. The current obv is -59,157,394.

Ironwood Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartIronwood Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ironwood Pharmaceuticals Inc. The current mfi is 53.44.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Ironwood Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartIronwood Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ironwood Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Ironwood Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ironwood Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.967
Ma 20Greater thanMa 504.187
Ma 50Greater thanMa 1004.350
Ma 100Greater thanMa 2005.173
OpenGreater thanClose4.040
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ironwood Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Ironwood Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ironwood Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ironwood Pharmaceuticals Inc

I send you an email if I find something interesting about Ironwood Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ironwood Pharmaceuticals Inc.

Receive notifications about Ironwood Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.